KRAS and pancreatic neoplasm: All 4 pancreatic cancer organoids pulsed with KRAS G12V 9-mer peptide greatly activated TCR-001–transduced allogeneic T cells (Figure 5E), indicating sufficient levels of HLA-A*11:01 on these organoids.